搜索页_+Prof+Ludwig+Kappos

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Opening Hours
Collections
Help Via Email

Electronic Information Resources

常用资源

内部出版物

CNKI学位论文(3)

在“Elsevier电子期刊”中，命中：17条，耗时：小于0.01 秒

在所有数据库中总计命中：3条

1.Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial

作者：Prof Ludwig Kappos ; MD^a ; ^{ludwig.kappos@usb.ch" class="auth_mail" title="E-mail the corresponding author} ; Prof Douglas L Arnold ; MD^b ; Prof Amit Bar-Or ; MD^b ; Prof John Camm ; MD^c ; Prof Tobias Derfuss ; MD^a ; Prof Bernd C Kieseier ; MD^d ; Prof Till Sprenger ; MD^a ; Kristin Greenough ; MSc^e ; Pingping Ni ; PhD^e ; Tomohiko Harada ; MD^e

刊名：Lancet Neurology

出版年：2016

2.Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies

作者：Gavin Giovannoni^a ; ^{g.giovannoni@qmul.ac.uk" class="auth_mail" title="E-mail the corresponding author} ; Ludwig Kappos^b ; ^{ludwig.kappos@usb.ch" class="auth_mail" title="E-mail the corresponding author} ; Ralf Gold^c ; ^{Ralf.Gold@ruhr-uni-bochum.de" class="auth_mail" title="E-mail the corresponding author} ; Bhupendra O Khatri^d ; ^{bokhatri@aol.com" class="auth_mail" title="E-mail the corresponding author} ; Krzysztof Selmaj^e ; ^{kselmaj@afazja.am.lodz.pl" class="auth_mail" title="E-mail the corresponding author} ; Kimberly Umans^f ; ^{kim.umans@biogen.com" class="auth_mail" title="E-mail the corresponding author} ; Steven J Greenberg^g ; ^{steven.greenberg@abbvie.com" class="auth_mail" title="E-mail the corresponding author} ; Marianne Sweetser^f ; ¹ ; ^{msweetser@alnylam.com" class="auth_mail" title="E-mail the corresponding author} ; Jacob Elkins^f ; ^{jake.elkins@biogen.com" class="auth_mail" title="E-mail the corresponding author} ; Peter McCroskery^f ; ^{peter.mccroskery@biogen.com" class="auth_mail" title="E-mail the corresponding author}

关键词：AE ; adverse event ; ALT ; alanine aminotransferase ; AST ; aspartate aminotransferase ; DRESS ; drug reaction with eosinophilia and systematic symptoms ; DSMB ; data safety monitoring board ; GGT ; gamma-glutamyl transferase ; GI ; gastrointestinal ; IL-2 ; interleukin 2 ; IM ; intramuscular ; MedDRA ; Medical Dictionary for Regulatory Activities ; MS ; multiple sclerosis ; RRMS ; relapsing-remitting multiple sclerosis ; SAE ; serious adverse event ; SMQ ; Standardised MedDRA Query ; SOC ; System Organ Class ; ULN ; upper li

刊名：Multiple Sclerosis and Related Disorders

出版年：2016

3.Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

作者：Prof Fred Lublin ; MD^a ; ^* ; ^{fred.lublin@mssm.edu" class="auth_mail" title="E-mail the corresponding author} ; Prof David H Miller ; FMedSci^b ; ^* ; Prof Mark S Freedman ; MD^c ; Prof Bruce A C Cree ; MD^d ; Prof Jerry S Wolinsky ; MD^e ; Prof Howard Weiner ; MD^f ; Prof Catherine Lubetzki ; MD^g ; Prof Hans-Peter Hartung ; MD^h ; Prof Xavier Montalban ; MDⁱ ; Prof Bernard M J Uitdehaag ; MD^j ; Martin Merschhemke ; MD^k ; Bingbing Li ; PhD^l ; Norman Putzki ; MD^k ; Fonda C Liu ; PharmD^l ; Dieter A Hä ; ring ; PhD^k ; Prof Ludwig Kappos ; MD^m ; on behalf of the INFORMS study investigators^&dagger ;

刊名：The Lancet

出版年：2016

4.MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

作者：Prof Massimo Filippi ; MD^a ; ^{filippi.massimo@hsr.it" class="auth_mail" title="E-mail the corresponding author} ; Maria A Rocca ; MD^a ; Prof Olga Ciccarelli ; PhD^b ; ^c ; Nicola De Stefano ; MD^d ; Nikos Evangelou ; PhD^e ; Prof Ludwig Kappos ; MD^f ; Alex Rovira ; MD^g ; Jaume Sastre-Garriga ; MD^h ; Mar Tintorè ; MD^h ; Prof Jette L Frederiksen ; MDⁱ ; Claudio Gasperini ; MD^j ; Jacqueline Palace ; MD^k ; Daniel S Reich ; MD^l ; Prof Brenda Banwell ; MD^m ; Prof Xavier Montalban ; MD^h ; Prof Frederik Barkhof ; MDⁿ ; on behalf of the MAGNIMS Study Group^&dagger ;

刊名：Lancet Neurology

出版年：2016

5.Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions

作者：Giancarlo Comi^a ; ^{g.comi@hsr.it" class="auth_mail" title="E-mail the corresponding author} ; Mark S Freedman^b ; ^{mfreedman@toh.on.ca" class="auth_mail" title="E-mail the corresponding author} ; Ludwig Kappos^c ; ^{Ludwig.Kappos@usb.ch" class="auth_mail" title="E-mail the corresponding author} ; Tomas P Olsson^d ; ^{Tomas.Olsson@ki.se" class="auth_mail" title="E-mail the corresponding author} ; Aaron E Miller^e ; ^{aaron.miller@mssm.edu" class="auth_mail" title="E-mail the corresponding author} ; Jerry S Wolinsky^f ; ^{Jerry.S.Wolinsky@uth.tmc.edu" class="auth_mail" title="E-mail the corresponding author} ; Paul W O'Connor^g ; ^{opaul362@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Myriam Benamor^h ; ^{Myriam.Benamor@sanofi.com" class="auth_mail" title="E-mail the corresponding author} ; Deborah Dukovicⁱ ; ^{Deborah.Dukovic@sanofi.com" class="auth_mail" title="E-mail the corresponding author} ; Philippe Truffinet^h ; ^{Philippe.Truffinet@sanofi.com" class="auth_mail" title="E-mail the corresponding author} ; Thomas P Leist^j ; ^{Thomas.Leist@jefferson.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Multiple sclerosis ; Relapsing-remitting multiple sclerosis ; Teriflunomide ; Safety analysis ; Clinical trials

刊名：Multiple Sclerosis and Related Disorders

出版年：2016

6.Efficacité et sécurité de l’ocrelizumab chez les patients atteints de sclérose en plaques récurrente : résultats d’OPERA I et II, études de phase III, en double-insu, double-placebo, versus interféron bêta-1a

作者：Sandra Vukusic¹ ; ^{sandra.vukusic@chu-lyon.fr" class="auth_mail" title="E-mail the corresponding author} ; Stephen L. Hauser² ; Douglas Arnold³ ; Anthony Traboulsee⁴ ; Gaelle Klingelschmitt⁵ ; Hideki Garren⁶ ; Ludwig Kappos⁷

关键词：SEP ré ; currente ; É ; tudes OPERA I et II ; Ocrelizumab

刊名：Revue Neurologique

出版年：2016

7.Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

作者：Dr Peter A Calabresi ; MD^a ; ^{pcalabr1@jhmi.edu" class="auth_mail} ; Prof Ernst-Wilhelm Radue ; MD^b ; Douglas Goodin ; MD^d ; Douglas Jeffery ; MD^e ; Kottil W Rammohan ; MD^f ; Anthony T Reder ; MD^g ; Timothy Vollmer ; MD^h ; Mark A Agius ; MDⁱ ; ^j ; Prof Ludwig Kappos ; MD^c ; Tracy Stites ; PhD^k ; Bingbing Li ; PhD^k ; Linda Cappiello ; MD^k ; Philipp von Rosenstiel ; MD^l ; Fred D Lublin ; MD^m

刊名：Lancet Neurology

出版年：June 2014

8.Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial

作者：Prof Ludwig Kappos ; MD^a ; ^{ludwig.kappos@usb.ch" class="auth_mail} ; Prof Hans-Peter Hartung ; MD^c ; Prof Mark S Freedman ; MD^d ; Prof Alexey Boyko ; MD^e ; Prof Ernst Wilhelm Radü ; MD^b ; Daniel D Mikol ; MD^f ; Marc Lamarine ; PhD^g ; Yann Hyvert ; PhD^h ; Ulrich Freudensprung ; MSⁱ ; Thomas Plitz ; PhD^j ; Johan van Beek ; PhD^k ; for the ATAMS Study Group &dagger

刊名：Lancet Neurology

出版年：April, 2014

9.Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial

作者：Christian Confavreux ; Paul O'Connor ; Giancarlo Comi ; Mark S Freedman ; Aaron E Miller ; Tomas P Olsson ; Jerry S Wolinsky ; Teresa Bagulho ; Jean-Luc Delhay ; Deborah Dukovic ; Philippe Truffinet ; Ludwig Kappos ; for the TOWER Trial Group

刊名：Lancet Neurology

出版年：March, 2014

10.Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study

作者：Virginia Devonshire ; MD^a ; Eva Havrdova ; MD^b ; Prof Ernst Wilhelm Radue ; MD^c ; Paul O'Connor ; MD^d ; Lixin Zhang-Auberson ; MD^e ; Catherine Agoropoulou ; PhD^e ; Dieter Adrian Hä ; ring ; PhD^e ; Gordon Francis ; MD^f ; Prof Ludwig Kappos ; MD^c ; ^{lkappos@uhbs.ch} ; for the FREEDOMS study group^&Dagger ;

刊名：Lancet Neurology

出版年：2012

1

2

按检索点细分(17)

作者(7)

按出版年细分(17)

2027年及以后(3)

2016年(6)

2012年(2)

2011年(1)

2009年(2)

2008年(2)

2001年(1)

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.